Keywords
trigeminal ganglion
facial pain
head and neck neoplasms
case reports
opioids.
Abstract
Introduction: Head and neck neoplasms cause severe pain and decreases quality of life in patients affected management of pain requires multimodal strategy with interventional procedures to control pain and lower opioids dosages. Case presentation: We identified ten patients attended at the National Institute of Cancerology in Bogotá, Colombia with diagnosis of head and neck neoplasia with relapse and progression who presented facial severe pain who have undergone a neurolytic block with alcohol to the Gasserian ganglion and observed a lower consumption of opioids and less score in the analog numerical scale of pain. Conclusion: This study shows the impact of interventional procedures to ameliorate pain in complex patients with severe facial pain. Describing this experience provides us with progress and a field of study and research that is beneficial for patients and the academic community.References
1. Khawaja SN, Scrivani SJ. Head and Neck Cancer-Related Pain. Dent Clin North Am. 2023;67(1):129-40.
2. Gupta B, Johnson NW, Kumar N. Global epidemiology of head and neck cancers: a continuing challenge. Oncology. 2016;91(1):13-23.
3. Silva-Ortiz VM, Plancarte-Sanchez R. Bipolar radiofrequency ablation for cancer pain in the trigeminal distribution. BMJ Support Palliat Care. 2024;13(e3):e981-3.
4. Khawaja SN, Scrivani SJ. Utilization of neurolysis in management of refractory head and neck cancer-related pain in palliative patients: A retrospective review. J Oral Pathol Med. 2020;49(6):484-9.
5. Mendelsohn D, Ranjan M, Hawley P, Honey CR. Percutaneous trigeminal rhizotomy for facial pain secondary to head and neck malignancy. Clin J Pain. 2013;29(10):e4-5.
6. Saravia A, Kong KA, Roy R, Barry R, Guidry C, McDaniel LS, et al. Referral Patterns of Outpatient Palliative Care among the Head and Neck Cancer Population. Int Arch Otorhinolaryngol. 2022;26(4):e538-e547.
7. Van Abel KM, Starkman S, O'Reilly AG, Price DL. Craniofacial pain secondary to occult head and neck tumors. Otolaryngol Head Neck Surg. 2014;150(5):813-7.
8. Chakraborty AR, Sunshine K, Miller JP, Sweet JA. Current Applications of Ablative Therapies for Trigeminal Neuralgia. Neurosurg Clin N Am. 2023;34(2):285-90.
9. Ahuactzin Avendaño TH, Guillen R, Segovia Sandoval KP, Juarez A, Sanchez Ortega AL, Viveros Aguilar FP. Effectiveness of Radiofrequency in Treating Pain Associated With Trigeminal Neuralgia in Oncologic Patients. Cureus. 2025;17(1):e76965.
10. Han KR, Chae YJ, Lee JD, Kim C. Trigeminal nerve block with alcohol for medically intractable classic trigeminal neuralgia: long-term clinical effectiveness on pain. Int J Med Sci. 2017;14(1):29-36.
11. Shah SA, Khan MN, Shah SF, Ghafoor A, Khattak A. Is peripheral alcohol injection of value in the treatment of trigeminal neuralgia? An analysis of 100 cases. Int J Oral Maxillofac. Surg. 2011;40(4):388-92.
12. Mirzadeh Z, Sheehy JP, Ben-Haim S, Rosenberg WS. Neurosurgical Management of Cancer Facial Pain. Prog Neurol Surg. 2020;35:170-80.
13. Bossi P, Giusti R, Tarsitano A, Airoldi M, De Sanctis V, Caspiani O, et al. The point of pain in head and neck cancer. Crit Rev Oncol Hematol. 2019;138:51-59.
14. Rossitch E Jr, Zeidman SM, Nashold BS Jr. Nucleus caudalis DREZ for facial pain due to cancer. Br J Neurosurg. 1989;3(1):45-9.
Licencia.
Los artículos publicados en RESED (Revista de la Sociedad Española del Dolor) se distribuyen bajo una licencia Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional (CC BY-NC-ND 4.0).
Esta licencia permite copiar y redistribuir el material en cualquier medio o formato, siempre que se cite adecuadamente la autoría y la fuente original. No se permite el uso comercial de la obra ni la distribución de obras derivadas.
Derechos de autoría.
Los derechos de explotación de los trabajos publicados corresponden a la Sociedad Española del Dolor. Las personas autoras conservan sus derechos morales sobre la obra y el derecho a difundirla conforme a los términos de la licencia.
Autoarchivo.
Se permite a las personas autoras depositar la versión publicada de su artículo en repositorios institucionales o temáticos y en su página web personal, citando la publicación original en RESED
Acceso abierto.
RESED es una revista de acceso abierto: todos sus contenidos son de libre acceso, sin coste para las personas lectoras ni para las autoras.